16 results
424B4
CGTX
Cognition Therapeutics, Inc.
14 Nov 22
Prospectus supplement with pricing info
6:02am
culture exposed to Aβ oligomer is shown below, before the addition of
CT1812, which is presented on the left, and after the addition of CT1812, which … by grants from the Michael J. Fox Foundation, α-synuclein oligomers were found to bind to brain cells in culture and are internalized, indicated
DRS
kg95k1o4s 6ood
20 Oct 22
Draft registration statement
12:00am
DEF 14A
0rt95 4dfj8g1q
25 Apr 22
Definitive proxy
5:28pm
10-K
6b22f27b0wq
30 Mar 22
Annual report
7:40am
10-Q
1uo99bjpdff nq9t
17 Nov 21
Quarterly report
5:15pm
424B4
uk0nezl154z6ylrzbjw
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
5ejvloovsu
19 Jul 21
IPO registration
7:02am
DRS/A
b8n iezw3
23 Jun 21
Draft registration statement (amended)
12:00am
DRS
12gpzbge32 yl
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next